Title: UK Diabetes Market Report and Outlook 2016
1 Imarc www.imarcgroup.com
Consulting Services
UK Diabetes Market Report 2016 - 2020
Copyright 2016 International Market Analysis
Research Consulting (IMARC). All Rights Reserved
2About IMARC Group
Imarc www.imarcgroup.com
Report Description
The International Market Analysis Research and
Consulting Group is a leading advisor on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, pharmaceuticals, food and beverage,
travel and tourism, nanotechnology and novel
processing methods are at the top of the
companys expertise. IMARCs tailored approach
combines unfathomable insight into the dynamics
of companies and markets with close cooperation
at all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3Report Description and Highlights
Imarc www.imarcgroup.com
Report Description
- UK Diabetes Market Report 2016 Industry
Analysis, Demographics, Diagnosis and Treatment
and Forecasts - MARCs new report UK Diabetes Market Report
2016 - 2020 provides an analytical and
statistical insight into the UK diabetes market.
The report provides both current and future
trends in the prevalence, demographical breakup,
diagnosis and treatment of diabetes in UK. The
research study serves as an exceptional tool to
understand the epidemiology, market trends,
therapeutic structure, competitive structure and
the outlook of the UK diabetes market. This
report can serve as an excellent guide for
investors, researchers, consultants, marketing
strategists and all those who are planning to
foray into the UK diabetes market in any form. - What we have achieved in this report
- Comprehensive situation analysis of the UK
diabetes epidemiology and its dynamics - Focus of the Analysis
- Historical, current and future prevalence of
diabetes in UK - Historical, current and future prevalence of
type-1 and type-2 diabetes in UK - Historical, current and future prevalence of
diabetes in the urban and rural regions in UK - Historical, current and future prevalence of
diabetes among males and females in UK - Historical, current and future prevalence of
diabetes among various age groups in UK - Historical, current and future diagnosis rates
for diabetes in UK - Historical, current and future drug treatment
rates for diabetes in UK
4Report Description and Highlights
Imarc www.imarcgroup.com
Report Description
- Comprehensive situation analysis of the UK Oral
Antidiabetics market and its dynamics - Focus of the Analysis
- Performance of the Oral Antidiabetics market in
Uk - Performance of key classes
- Performance of key players
- Market outlook
- Comprehensive situation analysis of the UK
Insulin market and its dynamics - Focus of the Analysis
- Performance of the Insulin market in Uk
- Performance of key classes
- Performance of key players
- Market outlook
5Uk Diabetes Market
Imarc www.imarcgroup.com
6Report Description and Highlights
Imarc www.imarcgroup.com
Report Description
Table of Contents 1 Research Methodology2
Executive Summary3 Diabetes Disease Overview3.1
What is Diabetes?3.2 Diabetes Diagnosis and
Treatment3.2.1 Diagnosis3.2.2 Treatment3.3
Diabetes Complications4 Key Factors Driving the
Diabetes Market in UK5 UK Diabetes
Epidemiology5.1 Diabetes Population and
Prevalence Rates5.2 Population and Prevalence
Rates by Diabetes Type (Type-1 and Type-2)5.3
Population and Prevalence Rates by Region5.4
Population and Prevalence Rates by Gender5.5
Population and Prevalence Rates by Age Group6 UK
Diabetes Market6.1 Historical Market Trends6.2
Market Outlook6.3 Market Breakup by Segment6.4
UK Oral Antidiabetics Market6.4.1 Historical
Market Trends6.4.2 Market Breakup by Class
7Report Description and Highlights
Imarc www.imarcgroup.com
Report Description
6.4.3 Market Shares of Key Players6.4.4 Market
Outlook6.5 UK Insulin Market6.5.1 Historical
Market Trends6.5.2 Market Breakup by Class6.5.3
Market Shares of Key Players6.5.4 Market
Outlook List of Figures Figure 3 1 The impact
of Diabetes in the Human BodyFigure 3 2
Diabetes ComplicationsFigure 4 1 Global
Breakup of Diabetes Patients by Region, (in )
2015 2035Figure 4 2 UK Overweight Obese
Population (in Million), 2010, 2015
2020Figure 4 3 Body Mass Index and Relative
risk of Type-2 DiabetesFigure 4 4 UK Breakup
of Total Population by Age Groups (0-14, 15-64
65), (in )Figure 4 5 UK Diabetes Prevalence
By Age Groups, (in )Figure 5 1 UK Total
Number of Diabetes Patients (in 000),
2008-2015Figure 5 2 UK Total Number of
Diabetes Patients Forecast (in 000),
2016-2020Figure 5 3 UK (Type1 Type2) Total
Number of Diabetes Patients (in 000), 2008-
2015Figure 5 4 UK (Type1 Type2) Total Number
of Diabetes Patients (in 000),2016-2020Figure 5
5 UK (Urban Rural) Total Number of Diabetes
Patients (in 000), 2008 -2015Figure 5 6 UK
(Urban Rural) Total Number of Diabetes
Patients (in 000), 2016 - 2020
8Report Description and Highlights
Imarc www.imarcgroup.com
Report Description
Figure 5 7 UK (Male Female) Total Number of
Diabetes Patients (in 000), 2008 - 2015Figure 5
8 UK (Male Female) Total Number of Diabetes
Patients (in 000), 2016 - 2020Figure 5 9 UK
Total Number of Diabetes Patients by Age Group
(20-39), (40-59) (60-79) (in 000), 2008 -
2015Figure 5 10 UK Total Number of Diabetes
Patients by Age Group (20-39), (40-59) (60-79)
(in 000), 2016 - 2020Figure 6 1 UK Diabetes
Drugs Market (in Million US), 2008 - 2015Figure
6 2 UK Diabetes Drug Market Forecast (in
Million US), 2016 - 2020Figure 6 3 UK
Diabetes Drugs Market Breakup of Insulin and
Oral Antidiabetics (in ), 2008- 2015Figure 6 4
UK Diabetes Drugs Market Forecast Breakup of
Insulin and Oral Antidiabetics (in ), 2016 -
2020Figure 6 5 UK Oral Antidiabetics Market
(in Million US), 2008 - 2015Figure 6 6 UK
Oral Antidiabetics Market Sales Share of Key
Classes (in ), 2008 2015Figure 6 7 UK Oral
Anti-diabetics Market Sales Share of Key Players
(in )Figure 6 8 UK Oral Antidiabetics Market
(in Million US), 2016 - 2020Figure 6 9 UK
Oral Antidiabetics Market Sales Share of Key
Classes (in ), 2016 2020Figure 6 10 UK
Insulin Market, (in Million US), 2008 -
2015Figure 6 11 UK Breakup of Insulin Market
by Class (in )Figure 6 12 UK Insulin Market
Sales Share of Key Players (in )Figure 6 13
UK Insulin Market Forecast (in Million US),
2016 - 2020
9Report Description and Highlights
Imarc www.imarcgroup.com
Report Description
List of Tables Table 3 1 Diagnosis of
DiabetesTable 4 1 Global Diabetes Population
Breakup by Country (in 000s), 2015 2035Table
4 2 UK Overweight Obesity Statistics, 2010,
2015 2020Table 4 3 UK Breakup of Total
Population by Age Groups (0-14, 15-64 65), (in
Million)Table 5 1 UK Total Prevalence Number
of Diabetes Patients, 2008, 2015 2020Table 5
2 UK (Type1 Type2) Total Prevalence Number
of Diabetes Patients, 2008, 2015 2020Table 5
3 UK (Urban Rural) Total Prevalence Number
of Diabetes Patients, 2008, 2015 2020Table 5
4 UK (Male Female) Total Prevalence Number
of Diabetes Patients, 2008, 2015 2020Table 5
5 Total Prevalence Number of Diabetes Patients
by Age Group (20-39), (40-59) (60-79) (In
Millions), 2008, 2015 2020
10Report Description and Highlights
Imarc www.imarcgroup.com
Report Description
To buy the complete report or to get a free
sample, please contact IMARC Group
AsiaEmail apac_at_imarcgroup.comPhone
91-120-415-5099 IMARC Group North
AmericaEmail america_at_imarcgroup.comPhone
1-631-791-1145 IMARC Group Europe, Middle East
AfricaEmailema_at_imarcgroup.comPhone
44-702-409-7331 To know more please visit
http//www.imarcgroup.com/UK-diabetes-market
11Report Description and Highlights
Imarc www.imarcgroup.com
Report Description
2016 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12Contact Us